SCHEMBL1998874

SCHEMBL1998874

O=C1CN(Cc2ccc(-c3ccc(F)c(CN4CCS(=O)(=O)CC4)c3)cc2)C(=O)N1CC1CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.35
KCNH2 Q12809 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
JAK2 O60674 3/20 0.34
TYK2 P29597 3/20 0.34
ENPP2 Q13822 2/20 0.34
HTR2A P28223 1/20 0.34
GRM2 Q14416 1/20 0.34
PARP1 P09874 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ICMT O60725 1/20 0.33
JAK1 P23458 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2001890 0.85 KMT2A (0.37) KMT2AMEN1ENPP2HTR2AGRM2
SCHEMBL1998115 0.85 LMNA (0.41) MCHR1KCNH2KMT2AMEN1JAK2
SCHEMBL1998199 0.83 ENPP2 (0.50) MCHR1KCNH2KMT2AMEN1JAK2
SCHEMBL1997682 0.76 PARP1 (0.44) ENPP2HTR2AGRM2PARP1HDAC1
SCHEMBL1999457 0.75 PARP1 (0.39) ENPP2HTR2AGRM2PARP1PARP2
SCHEMBL1995187 0.75 PARP1 (0.39) ENPP2HTR2AGRM2PARP1PARP2
SCHEMBL1995190 0.75 PARP1 (0.39) ENPP2HTR2AGRM2PARP1PARP2
Hydrochloric Acid SCHEMBL2502392 0.74 PARP1 (0.39) ENPP2HTR2AGRM2PARP1PARP2
Hydrochloric Acid SCHEMBL2502390 0.74 PARP1 (0.39) ENPP2HTR2AGRM2PARP1PARP2
SCHEMBL1997243 0.74 HRH3 (0.44) MCHR1ENPP2HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US claimed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US claimed
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 MCHR1 663/4885KCNH2 123/4885KMT2A 1431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.